ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682765 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682765; 2) Community: the network communities that were significantly associated with the response to NSC 682765; 3) Molecule: the relationships between components within communities and NSC 682765; 4) MDR: the compounds that were significantly associated with the NSC 682765.

NSC Compound Enrichment Correlation
NSC 681646 Camptothecin Derivative 0.0100967765290133 0.066966836
NSC 736811 Null 0.0100967765290133 -0.15169361
NSC 756404 GW843682X 0.0100967765290133 -0.2537217
NSC 763059 Paracymene-ruthenium(II)-[N-(3-(1H-imidazol-1-yl)propyl)-4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8 tetrahydronaphthalen-2-yl)vinyl)benzamide] dichloride 0.0100967765290133 -0.096531299
NSC 105014 Cladribine 0.0135588245836371 -0.12465855
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.0135588245836371 -0.26167206
NSC 269720 Androstan-17-one, 3-[[[(2-chloroethyl)nitrosoamino]carbonyl]oxy]-, (3.alpha.,5.alpha.)- 0.0135588245836371 0.022959757
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.0135588245836371 -0.16857815
NSC 313681 Oxiperomide(USAN) 0.0135588245836371 -0.041320601
NSC 328410 Camptothecin Derivative 0.0135588245836371 -0.0060824098
Total:63  Current:12    [First] [Prev] [Next] [Last]